Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2861
Selected: 0
NCT IDTitle
NCT02089061Drug Interaction Statin
NCT02283294Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
NCT01573351Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
NCT05743270Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
NCT00122382Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT01471223Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study
NCT02343042Selinexor and Backbone Treatments of Multiple Myeloma Patients
NCT03414983An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
NCT02805010Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
NCT02538666An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy
NCT05662241A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
NCT03382886Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma
NCT03877770DVT After Cardiac Procedure
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
NCT02933346Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
NCT02553642Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
NCT00357370A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
NCT01685905The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
NCT03333746Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT03712540An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants
NCT05434689COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
NCT01052389Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
NCT03245021Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A
NCT05232643A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
NCT00350038Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
NCT03016325Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
NCT03329885A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
NCT00350025Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
NCT01525238PK Study of Dapagliflozin in Pediatric Subjects With T2DM
NCT00578448Belatacept Pharmacokinetic Trial in Renal Transplantation
NCT02857426A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
NCT01492426Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
NCT06003426A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
NCT05405543A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants
NCT00444015Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)
NCT05502315Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
NCT01055691A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
NCT04311710A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types
NCT02017717A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
NCT03590210Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas
NCT03161379GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
NCT00123474Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
NCT01471574Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
NCT00193310Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer
NCT02095860Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325
NCT05200143Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
NCT02526017Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
NCT03558750Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma
NCT03214250Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
NCT04863885Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients